Axiom Investment Management LLC Amgen Inc Transaction History

Axiom Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Mar 16, 2021	SELL	$174.11 - $208.62 $1.21 Million - $1.45 Million	-6,939 Closed	0 $0
Q2 2019 Mar 16, 2021	SELL	$166.7 - $195.41 $207,208 - $242,894	-1,243 Reduced 15.19%	6,939 $1.28 Million
Q1 2019 Mar 16, 2021	SELL	$180.87 - $203.88 $2 Million - $2.25 Million	-11,041 Reduced 57.44%	8,182 $1.55 Million
Q4 2018 Oct 23, 2020	BUY	$178.4 - $208.25 $3.43 Million - $4 Million	19,223 New	19,223 $3.74 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Axiom Investment Management LLC with notifications on news.